Parmax Pharma Schedules EGM for July 2, 2026

Parmax Pharma Ltd has announced an Extra-Ordinary General Meeting (EGM) to be held on July 2, 2026, via Video Conferencing. The primary agenda items include increasing the company's authorized share capital from ₹6 Crores to ₹10 Crores by creating an additional 40,00,000 equity shares, and altering the Memorandum of Association accordingly. Additionally, the EGM will consider adopting a new set of Articles of Association. The cut-off date for e-voting eligibility is June 25, 2026, with remote e-voting commencing on June 29 and concluding on July 1, 2026.